Pipeline Previews

By No Comments
FDA Approves Sorilux Stiefel has announced that the FDA has approved a supplemental New Drug Application (sNDA) for Sorilux (calcipotriene) Foam, 0.005%. The sNDA expands the indication for Sorilux Foam…
Read More